Drug intelligence / Profile preview

CN54gp140 + GLA-AF

Development stage
Unknown
Lead developer
St. George's University of London
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

CN54gp140 + GLA-AF is a combination vaccine formulation consisting of a recombinant HIV envelope protein (CN54gp140) and a synthetic adjuvant (GLA-AF). CN54gp140 is a soluble, trimeric form of the HIV envelope from the C/B' strain 97/CN/54, expressed in CHO cells. GLA-AF (Glucopyranosyl Lipid Adjuvant-Aqueous Formulation) is a synthetic hexaacylated lipid A derivative that acts as a TLR-4 agonist. This combination has been used in HIV vaccine clinical trials, typically administered intramuscularly at a dosage of 100 μg CN54gp140 with 5 μg GLA-AF.

Other names
CN54gp140 HIV vaccineCN-54gp140 HIV vaccineCN 54gp140 HIV vaccine97CN54gp140HIV-1 clade C envelope protein vaccineHIV1 clade C envelope protein vaccineHIV 1 clade C envelope protein vaccine
02

Targets

TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on CN54gp140 + GLA-AF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CN54gp140 + GLA-AF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call